Peripheral CD8+ T Cell Dynamics and Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Following Bronchoscopic Cryotherapy and Pembrolizumab-Based Therapy
Gediminas Vasiliauskas, Evelina Žemaitė, Erika Skrodenienė, Lina Poškienė, Skaidrius Miliauskas, Marius Žemaitis · 2026
Read Peripheral CD8+ T Cell Dynamics and Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Following Bronchoscopic Cryotherapy and Pembrolizumab-Based Therapy by Gediminas Vasiliauskas, Evelina Žemaitė, Erika Skrodenienė, Lina Poškienė, Skaidrius Miliauskas, Marius Žemaitis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13255720.txt.
Description
Gediminas Vasiliauskas and colleagues report a 2026 study pairing airway cryotherapy with immunotherapy in metastatic non-small cell lung cancer. Freezing tumor tissue through a bronchoscope clears airways, and the injury may also expose tumor proteins that train the immune system. Patients received cryotherapy before pembrolizumab-based treatment, and their blood was compared with patients on standard treatment alone.
The team focused on CD8-positive T cells, the immune cells that kill cancer. Cryotherapy patients showed signs of stronger antitumor immune activity. Early rises in dividing CD8 cells were linked to better treatment outcomes. The authors propose these blood patterns as candidate markers for who benefits from the combination. They frame cryotherapy as possible immune conditioning rather than only a mechanical fix for blocked airways.
Catalog record
| CREATOR | Gediminas Vasiliauskas, Evelina Žemaitė, Erika Skrodenienė, Lina Poškienė, Skaidrius Miliauskas, Marius Žemaitis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |